BOSULIF

Sobre este medicamento

Originator: BOSULIF by PF PRISM CV · Manufacturer: GLAXOSMITHKLINE Pharma. Indication & Dosage: BOSULIF (BOSUTINIB MONOHYDRATE), is a prescription medicine used to treat certain types of blood cancer (chronic myelogenous leukemia-CML). BOSUTINIB MONOHYDRATE also works for adult patients with Newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML). BOSULIF is Manufactured by GlaxoSmithKline Pharma Ltd. in Germany. BOSUTINIB MONOHYDRATE has to take orally once daily. Side Effects: The most common adverse reactions of BOSUTINIB MONOHYDRATE are: Nausea , vomiting , stomach / abdominal pain , loss of appetite, cough, joint pain, headache, or dizziness. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.